Ying Wang

10PUBLICATIONS
21CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 21, 2026
Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia.

|Sep 05, 2025
Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong, Wenbing Liu, Yuntao Liu

|Aug 09, 2025
Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia.

Yu Liu, Wenbing Liu, Yihan Mei

|Jun 30, 2025
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong, Wenbing Liu, Yuntao Liu

|Dec 03, 2024
Inaticabtagene autoleucel in adult relapsed or refractory B-cell acute lymphoblastic leukemia.

Ying Wang, Lulu Lv, Yongping Song

|Nov 01, 2024
The dynamic evolution of lineage switch under CD19 CAR-T treatment in non-KMT2A rearranged B-ALL patients.

Shaowei Qiu, Yihan Mei, Runxia Gu

Pageof 2

Frequent Collaborators

6 joint publications

Jianxiang Wang

5 joint publications

Shaowei Qiu

5 joint publications

Runxia Gu

5 joint publications

Hui Wei